Editorial
doi: 10.1136/bmj.i2874.
The cardiovascular safety of methylphenidate
Affiliations
- PMID: 27245078
- PMCID: PMC4887615
- DOI: 10.1136/bmj.i2874
Item in Clipboard
Editorial
The cardiovascular safety of methylphenidate
BMJ.
.
Abstract
What to make of studies that agree to disagree
Conflict of interest statement
Competing interests: I have read and understood the BMJ Group policy on declaration of interests and declare the following interests: none.
Comment on
- Research, doi: 10.1136/bmj.i2550
Similar articles
-
Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study.BMJ. 2016 May 31;353:i2550. doi: 10.1136/bmj.i2550. BMJ. 2016. PMID: 27245699 Free PMC article.
-
Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report.Int J Eat Disord. 1997 Apr;21(3):299-301. doi: 10.1002/(sici)1098-108x(199704)21:3<299::aid-eat11>3.0.co;2-w. Int J Eat Disord. 1997. PMID: 9097204
-
Methylphenidate for Comorbid Epilepsy and Attention-Deficit/Hyperactivity Disorder.Am J Ther. 2019 Nov/Dec;26(6):e718-e720. doi: 10.1097/MJT.0000000000000873. Am J Ther. 2019. PMID: 31567149 No abstract available.
-
Stimulants and tic disorders: from dogma to data.Arch Gen Psychiatry. 1999 Apr;56(4):337-8. doi: 10.1001/archpsyc.56.4.337. Arch Gen Psychiatry. 1999. PMID: 10197828 Review. No abstract available.
-
[Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].Harefuah. 1997 May 1;132(9):672-5. Harefuah. 1997. PMID: 9225587 Review. Hebrew. No abstract available.
Cited by
-
Association between methylphenidate use and long-term cardiovascular risk in paediatric patients with attention deficit and hyperactivity disorder.BMJ Paediatr Open. 2024 Sep 3;8(1):e002753. doi: 10.1136/bmjpo-2024-002753. BMJ Paediatr Open. 2024. PMID: 39231572 Free PMC article.
-
Efficacy and tolerability of psychostimulants for symptoms of attention-deficit hyperactivity disorder in preschool children: A systematic review and meta-analysis.Eur Psychiatry. 2023 Feb 15;66(1):e24. doi: 10.1192/j.eurpsy.2023.11. Eur Psychiatry. 2023. PMID: 36788670 Free PMC article. Review.
-
Acute myocardial infarction due to spontaneous coronary artery dissection in a 6-year-old boy with ADHD on the third day of treatment with methylphenidate.Eur Child Adolesc Psychiatry. 2022 Jun;31(6):939-945. doi: 10.1007/s00787-021-01729-2. Epub 2021 Feb 3. Eur Child Adolesc Psychiatry. 2022. PMID: 33537905
-
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2. Cochrane Database Syst Rev. 2018. PMID: 29744873 Free PMC article. Review.
References
-
- Chai G, Governale L, McMahon AW, Trinidad JP, Staffa J, Murphy D. Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics 2012;130:23-31. 10.1542/peds.2011-2879 pmid:22711728. - DOI - PubMed
-
- Munk K, Gormsen L, Kim WY, Andersen NH. Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate. Case Rep Pediatr 2015;2015:905097 10.1155/2015/905097 pmid:26221559. - DOI - PMC - PubMed
-
- Martinez-Raga J, Knecht C, Szerman N, Martinez MI. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs 2013;27:15-30. 10.1007/s40263-012-0019-9 pmid:23160939. - DOI - PubMed
-
- Winterstein AG, Gerhard T, Kubilis P, et al. Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study. BMJ 2012;345:e4627 10.1136/bmj.e4627 pmid:22809800. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
